About TargEDys
TargEDys is a Healthcare company based in Rouen (France) founded in 2015, and was acquired by Biocodex in June 2023. Microbiome-based solutions for appetite regulation and metabolic control are provided. TargEDys has raised $10.28 million across 3 funding rounds from investors including Biocodex, Seventure Partners and NCI. Its focus areas include Life Sciences, Microbiome Therapeutics, Probiotics and Metabolic Diseases.
Company details
TargEDys was founded in 2015 and is based in Rouen, France. Operations focus on the development and manufacturing of nutritional solutions derived from the microbiome to address metabolic diseases. Key products include Hafnia alvei HA4597 for weight management, probiotic formulations for growth and nutrition optimization, and PreciBiomic Strains targeted at stress and anxiety management. The company operates within the biotech and nutraceutical sectors.
- Headquarters Rouen, France
- Stage Acquired
- SectorsHealthcare
- Website targedys.com
- Social LinkedIn X
- Acquired by Biocodex (Jun 2023)
Funding Insights of TargEDys
TargEDys has successfully raised a total of $10.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.28M
- Total Rounds 3
- First Round $6.57M
(Apr 2016)
- Investors Count 5
All 3 funding rounds of TargEDys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2019 | Series A | – | Biocodex | ||
| Apr 2017 | $3.71M | Series A | – | – | |
| Apr 2016 | $6.57M | Series A | – | Seventure Partners, NCI | – |
5 investors in total: 5 institutional.
Investors in TargEDys
TargEDys has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Biocodex, Seventure Partners and NCI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US | seventure.fr | Paris, France | ||
NCI is engaged in regional private equity investment in France. | 2000 | n-ci.com | Rouen, France | |
Pontifax Venture Capital is focused on life sciences investments. | pontifax.com | Herzeliya, Israel | ||
| biocodex.com | ||||
Zaluvida is engaged in building science-led ventures for impact. | zaluvida.com |
Investor details for TargEDys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TargEDys
3 people are tracked at TargEDys (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Sergueï Fetissov | Scientific advisor and co-founder | Leadership |
Clémentine Trotin-Picolo | Technical Director | Leadership |
✨ Arnaud Faure | Marketing Manager | Team |
Complete people profiles for TargEDys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TargEDys
4 dated milestones of TargEDys across 8 years, from founding to its latest funding, stage changes and deals.
- Founded TargEDys is founded.
- Funding First funding round of $6.6M.
- Funding Latest funding round, Series A,.
- Exit Acquired by Biocodex.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Targedys
Complete news archive for TargEDys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TargEDys
TargEDys was founded in 2015 and raised its 1st funding round 1 year after it was founded.
TargEDys is headquartered in Rouen, France. It is registered at Rouen, Normandie, France.
TargEDys is a funded company, having raised a total of $10.28M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6.57M, raised on Apr 2016.
TargEDys was founded in 2015 and is based in Rouen, France. Operations focus on the development and manufacturing of nutritional solutions derived from the microbiome to address metabolic diseases. Key products include Hafnia alvei HA4597 for weight management, probiotic formulations for growth and nutrition optimization, and PreciBiomic Strains targeted at stress and anxiety management. The company operates within the biotech and nutraceutical sectors.
TargEDys has 5 investors. Key investors include Biocodex, Seventure Partners, NCI, Zaluvida, and Pontifax Venture Capital.
Yes. TargEDys was acquired by Biocodex in June 2023.